Proteomics Research of Osteosarcoma

NCT03932058 · clinicaltrials.gov ↗

UNKNOWN

Status

400

Enrollment

OTHER

Sponsor class

Conditions

Osteosarcoma
Proteomics

Interventions

DRUG: Chemotherapy

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University